Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    1100130 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
Condition: Alzheimer Disease
Intervention: Drug: [123I] IMPY & SPECT Imaging
2 Enrolling by invitation Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures
Condition: Tobacco Use Disorder
Interventions: Behavioral: Usual Care;   Behavioral: Individual Rewards;   Behavioral: Fixed Deposits;   Behavioral: Competitive Deposits (Pari-Mutuel);   Behavioral: Collaborative Rewards
3 Active, not recruiting Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Erlotinib;   Drug: Docetaxel
4 Completed Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
Conditions: Acquired Immunodeficiency Syndrome;   Aspergillosis;   HIV Infections;   Immunologic Deficiency Syndromes;   Neutropenia
Interventions: Drug: Voriconazole;   Drug: Amphotericin B
5 Recruiting Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Weekly cisplatin with RT;   Drug: Tri-weekly cisplatin with RT

Indicates status has not been verified in more than two years